ArticleTransboundary and emerging diseases2026
Prevalence and Molecular Characterization of Enterocytozoon bieneusi in Horses From Northern and Eastern China: Investigation of Associated Risk Factors and Assessment of Zoonotic Potential.
Article in Transboundary and emerging diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and Molecular Characterization of Enterocytozoon bieneusi in Horses From Northern and Eastern China: Investigation of Associated Risk Factors and Assessment of Zoonotic Potential.Transboundary and emerging diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Enterocytozoon bieneusi is a zoonotic microsporidian threatening public health, yet epidemiological data on equine infections in China are scarce despite frequent human-horse contact. In this study, 412 fresh horse fecal samples were collected from four Chinese regions covering four rearing systems and were screened for E. bieneusi internal transcribed spacer (ITS) sequences via nested PCR, with risk factor and phylogenetic analyses conducted. The overall infection prevalence reached 15.0% (62/412), varying geographically from 9.7% (Wenzhou) to 29.3% (Qiqihar). Foals <1 year and male horses exhibited significantly higher infection risks, with crude prevalence ratios (PRs) of 4.47 and 2.28, respectively, while prevalence did not differ statistically across rearing modes (p = 0.182). Eighteen genotypes were identified: 11 known (D, horse1, Peru8, Type IV, EbpC, CAF1, GX3, HNR-VI, SHWR5, SYSWR18, SYSWR23) and seven novel (HRBM1, KDM1, KDM2, QQHRM1, QQHRM2, QQHRM3, WZM1). Genotype D was dominant, accounting for 58.1% (36/62) of positive isolates, followed by genotype horse1 at 14.5% (9/62) and genotype EbpC at 3.2% (2/62). The other eight known genotypes and all seven novel genotypes each had one isolate. All seven novel genotypes clustered within zoonotic Group 1 with all the known genotypes except HNR-VI identified here. This study confirms widespread equine E. bieneusi circulation across eastern and northern China, modulated by geography, age, and sex. The predominance of zoonotic genotypes implies horses serve as potential reservoirs for human transmission, supplying baseline epidemiological evidence for equine One Health biosecurity management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.